Solventum corporationSOLV.US Overview
SOLV Overall Performance
SOLV AI Analysis & Strategy
Browsing restrictions can be lifted for a fee.
SOLV Key Information
SOLV Financial Forecast
Browsing restrictions can be lifted for a fee.
| Quarterly | EPS Forecast | QoQ | Max | Min |
|---|---|---|---|---|
| 2025Q1 | ||||
| 2025Q2 | ||||
| 2025Q3 | ||||
| 2025Q4 | ||||
| 2026Q1 |
SOLV Earnings Table
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | |||||||
| 2024Q4 | |||||||
| 2024Q3 | |||||||
| 2024Q2 | |||||||
| 2024Q1 |
SOLV Profile
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
Price of SOLV
SOLV FAQ
When is SOLV's latest earnings report released?
The most recent financial report for Solventum corporation (SOLV) covers the period of 2025Q2 and was published on 2025/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating SOLV's short-term business performance and financial health. For the latest updates on SOLV's earnings releases, visit this page regularly.
Where does SOLV fall in the P/E River chart?
According to historical valuation range analysis, Solventum corporation (SOLV)'s current price-to-earnings (P/E) ratio is 33.49, placing it in the Overvalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning optimistic. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.
What is the operating profit of SOLV?
According to the latest financial report, Solventum corporation (SOLV) reported an Operating Profit of 214M with an Operating Margin of 9.9% this period, representing a decline of 12.3% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
How is SOLV's revenue growth?
In the latest financial report, Solventum corporation (SOLV) announced revenue of 2.16B, with a Year-Over-Year growth rate of 3.84%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
How much cash does SOLV have?
At the end of the period, Solventum corporation (SOLV) held Total Cash and Cash Equivalents of 492M, accounting for 0.03 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
Does SOLV go with three margins increasing?
In the latest report, Solventum corporation (SOLV) achieved the “three margins increasing” benchmark, with a gross margin of 54.4%%, operating margin of 9.9%%, and net margin of 4.2%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess SOLV's profit trajectory and future growth potential.
Is SOLV's EPS continuing to grow?
According to the past four quarterly reports, Solventum corporation (SOLV)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.52. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
What is the FCF of SOLV?
Solventum corporation (SOLV)'s Free Cash Flow (FCF) for the period is 59M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 80.13% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.
What are the PEG ratio and PE ratio of SOLV?
The latest valuation data shows Solventum corporation (SOLV) has a Price-To-Earnings (PE) ratio of 33.49 and a Price/Earnings-To-Growth (PEG) ratio of -1.07. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.